Renal biomarkers currently used in CKD diagnosis and the assessment of its course, such as estimated glomerular filtration rate (eGFR), albuminuria, creatinine, urea, uric acid, cystatin C are lacking appropriate sensitivity and specificity for early stage CKD patients, which leads to the delayed intervention [33]. The gene discussed is CST3; the disease is chronic kidney disease.